Cardiovascular Toxicology

, Volume 4, Issue 4, pp 317–325 | Cite as

Dilated cardiomyopathy in retrovirally infected mice

A novel model for silent viral DCM?
  • Julie Beischel
  • Douglas F. Larson
  • Qianli Yu
  • Bo Yang
  • Ramon Tomas Sepúlveda
  • Tara Kelley
  • Ronald R. Watson
Original Research


Dilated cardiomyopathy (DCM) is a clinically relevant disease that can occur independently or secondary to other diseases such as HIV infection and AIDS. To study this latter process, we used a model in which mice are infected with the LP-BM5 murine AIDS (MAIDS) retrovirus. Cardiac function of control and infected mice was determined through the in vivo analysis of left ventricular pressure-volume loops. Furthermore, the role of myocarditis was investigated through immunohistochemistry for T-cell, B-cell, and macrophage cardiac infiltrates and Northern blot analysis for tumor necrosis factor (TNF)-α and inducible nitric oxide synthase (iNOS). End-systolic and end-diastolic volumes were significantly increased and ventricular stiffness was significantly decreased in infected mice, consistent with DCM; however, no staining for inflammatory cellular infiltrates or TNF-α and iNOS was seen. These data support the conclusion that the LP-BM5 HIV model virus causes DCM in the absence of chronic cardiac inflammation. These findings support MAIDS retroviral infection as a new model of idiopathic DCM in which myocarditis does not occur.

Key Words

Dilated cardiomyopathy murine acquired immunodeficiency syndrome viral myocarditis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Heart Association. (2002). Heart Disease and Stroke Statistics—2003 Update. American Heart Association, Dallas, TX.Google Scholar
  2. 2.
    Towbin, J.A. and Bowles, N.E. (2000). Genetic abnormalities responsible for dilated cardiomyopathy. Curr. Cardiol. Rep. 2:475–480.PubMedGoogle Scholar
  3. 3.
    Bachinski, L.L. and Roberts, R. (1998). New theories: causes of dilated cardiomyopathy. Cardiol. Clin. 16:603–610.PubMedCrossRefGoogle Scholar
  4. 4.
    Mestroni, L., Rocco, C., Vatta, M., Miocic, S., and Giacca, M. (1998). Advances in molecular genetics of dilated cardiomyopathy. Cardiol. Clin. 16:611–621.PubMedCrossRefGoogle Scholar
  5. 5.
    Kearney, M.T., Cotton, J.M., Richardson, P.J., and Shah, A.M. (2001). Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad. Med. J. 77:4–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Gluck, B., Schmidtke, M., Merkle, I., Stelzner, A., and Gemsa, D. (2001). Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. J. Mol. Cell. Cardiol. 33:1615–1626.PubMedCrossRefGoogle Scholar
  7. 7.
    Habib, F.M., Springall, D.R., Davies, G.J., Oakley, C.M., Yacoub, M.H., and Polak, J.M. (1996). Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347:1151–1155.PubMedCrossRefGoogle Scholar
  8. 8.
    Lipshultz, S.E. (1998). Dilated cardiomyopathy in HIV-infected patients. N. Engl. J. Med. 339:1153–1155.PubMedCrossRefGoogle Scholar
  9. 9.
    Barbaro, G. and Lipshultz, S.E. (2001). Pathogenesis of HIV-associated cardiomyopathy. Ann. NY Acad. Sci. 946: 57–81.PubMedCrossRefGoogle Scholar
  10. 10.
    Fisher, S.D. and Lipshultz, S.E. (2001). Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann. NY Acad. Sci. 946:13–22.PubMedCrossRefGoogle Scholar
  11. 11.
    d'Amati, G., di Gioia, C.R., and Gallo P. (2001). Pathological findings of HIV-associated cardiovascular disease. Ann. NY Acad. Sci. 946:23–45.PubMedCrossRefGoogle Scholar
  12. 12.
    Barbaro, G., Di Lorenzo, G., Grisorio, B., and Barbarini, G. (1998). Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients, Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N. Engl. J. Med. 339:1093–1099.PubMedCrossRefGoogle Scholar
  13. 13.
    Anderson, D.W., Virmani, R., Reilly, J.M., O'Leary, T., Cunnion, R.E., Robinowitz, M., et al. (1988). Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J. Am. Coll. Cardiol. 11:792–799.PubMedCrossRefGoogle Scholar
  14. 14.
    Himelman, R.B., Chung, W.S., Chernoff, D.N., Schiller, N.B., and Hollander, H. (1989). Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J. Am. Coll. Cardiol. 13: 1030–1036.PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen, I.S., Anderson, D.W., Virmani, R., Reen, B.M., Macher, A.M., Sennesh, J., et al. (1986). Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N. Engl. J. Med. 315:628–630.PubMedCrossRefGoogle Scholar
  16. 16.
    Barbaro, G. (2001). Cardiovascular manifestations of HIV infection. J. R. Soc. Med. 94:384–390.PubMedGoogle Scholar
  17. 17.
    Felker, G.M., Thompson, R.E., Hare, J.M., Hruban, R.H., Clemetson, D.E., Howard, D.L., et al. (2000). Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 342:1077–1084.PubMedCrossRefGoogle Scholar
  18. 18.
    Barbaro, G., Di Lorenzo, G., Soldini, M., Giancaspro, G., Grisorio, B., Pellicelli, A., et al. (1999). Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 100:933–939.PubMedGoogle Scholar
  19. 19.
    Chattopadhyay, S.K., Sengupta, D.N., Fredrickson, T.N., Morse, H.C. 3rd, and Hartley, J.W. (1991). Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J. Virol. 65: 4232–4241.PubMedGoogle Scholar
  20. 20.
    Liang, B., Wang, J.Y., and Watson, R.R. (1996). Murine AIDS, a key to understanding retrovirus-induced immuno-deficiency. Viral Immunol. 9:225–239.PubMedCrossRefGoogle Scholar
  21. 21.
    Opie, L.H. (1998) The Heart: Physiology from Cell to Circulation. Lippincott-Raven Publishers, Philadelphia.Google Scholar
  22. 22.
    Sepúlveda, R.T., Jiang, S., Beischel, J., Bellamy, W.T., and Watson, R.R. (2000). Cocaine injection and coxsackie B3 infection increase heart disease during murine AIDS. J. Acquir. Immune Defic. Syndr. 25(Suppl. 1):S19-S26.PubMedCrossRefGoogle Scholar
  23. 23.
    Yang, B., Larson, D.F., Beischel, J., Kelly, R., Shi, J., and Watson, R.R. (2001). Validation of conductance catheter system for quantification of murine pressure-volume loops. J. Invest. Surg. 14:341–355.PubMedCrossRefGoogle Scholar
  24. 24.
    Glower, D.D., Spratt, J.A., Snow, N.D., Kabas, J.S., Davis, J.W., Olsen, C.O., et al. (1985). Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71:994–1009.PubMedGoogle Scholar
  25. 25.
    Kass, D.A., Yamazaki, T., Burkhoff, D., Maughan, W.L., and Sagawa, K. (1986). Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 73:586–595.PubMedGoogle Scholar
  26. 26.
    Casabianca, A., Vallanti, G., and Magnani, M. (1998). Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS. J. Clin. Microbiol. 36:2371–2374.PubMedGoogle Scholar
  27. 27.
    Sanderson, J.E. (1997). Diastolic heart failure and the extracellular matrix. Int. J. Cardiol. 62(Suppl. 1):S19-S21.PubMedCrossRefGoogle Scholar
  28. 28.
    Parrillo, J.E., Aretz, H.T., Palacios, I., Fallon, J.T., and Block, P.C. (1984). The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 69:93–101.PubMedGoogle Scholar
  29. 29.
    Di Somma, S., Marotta, M., Salvatore, G., Cudemo, G., Cuda, G., De Vivo, F., et al. (2000). Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart 84:659–667.PubMedCrossRefGoogle Scholar
  30. 30.
    Tyagi, S.C., Kumar, S., Voelker, D.J., Reddy, H.K., Janicki, J.S., and Curtis, J.J. (1996). Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J. Cell. Biochem. 63:185–198.PubMedCrossRefGoogle Scholar
  31. 31.
    Weiss, L.M., Liu, X.F., Chang, K.L., and Billingham, M.E. (1992). Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J. Clin. Invest. 90:156–159.PubMedCrossRefGoogle Scholar
  32. 32.
    Klingel, K., Hohenadl, C., Canu, A., Albrecht, M., Seemann, M., Mall, G., et al. (1992). Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89:314–318.PubMedCrossRefGoogle Scholar
  33. 33.
    Obrador, D., Ballester, M., Carrio, I., Auge, J.M., Lopez, C.M., Bosch, I., et al. (1993). Active myocardial damage without attending inflammatory response indilated cardiomyopathy. J. Am. Coll. Cardiol. 21:1667–1671.PubMedCrossRefGoogle Scholar
  34. 34.
    Elliott, P. (2000). Cardiomyopathy: diagnosis and management of dilated cardiomyopathy. Heart 84:106–112.PubMedCrossRefGoogle Scholar
  35. 35.
    Manolio, T.A., Baughman, K.L., Rodeheffer, R., Pearson, T.A., Bristow, J.D., Michels, V.V., et al. (1992). Prevalence and etiology of idiopathic dilated cardiomyopathy. Am. J. Cardiol. 69:1458–1466.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2004

Authors and Affiliations

  • Julie Beischel
    • 1
  • Douglas F. Larson
    • 1
  • Qianli Yu
    • 1
    • 2
  • Bo Yang
    • 1
  • Ramon Tomas Sepúlveda
    • 2
  • Tara Kelley
    • 1
  • Ronald R. Watson
    • 2
  1. 1.Sarver Heart CenterTucson
  2. 2.Arizona Prevention CenterTucson

Personalised recommendations